Skip to main content

Odyssey Health, Inc.

corporate_fare Company Profile

Odyssey Health, Inc.

ODYY·OTC·Industrial Applications And Services·CIK 0001626644

Odyssey Health, Inc. is a publicly held company that acquires and develops medical products. The company focuses on technologies with a technological advantage, superior clinical utility, and substantial market opportunities globally. Odyssey Health, Inc. operates through its subsidiaries, Odyssey Medical Devices, Inc. and Odyssey Group International Australia, Pty Ltd. Its business model involves developing or acquiring medical-related products, engaging third parties for development and manufacturing, and then distributing these products through various channels, including third parties. The company currently has two technologies in the research and development stage: the CardioMap heart monitoring and screening device and the Save-A-Life choking rescue device. As of now, none of its product candidates have received regulatory clearance or approval for commercial sale. Odyssey Health, Inc. plans to acquire additional technologies and assets to become a trans-disciplinary product development company, involved in developing and commercializing products and technologies applicable across various medical markets. The company was formed as a Nevada corporation in March 2014, and its shares of common stock are listed on the OTCQB Marketplace.

Odyssey Health, Inc. (OTC:ODYY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 7 items for ODYY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-12, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ODYY spans 10-Q, 8-K.

Recent high-impact activity:

  • Odyssey Health Swings to Q3 Net Income of $766K, Reports $0.01 EPS
  • Odyssey Health Reports Worsening Financials, Going Concern Warning, and Key Agreement Termination
  • Odyssey Health Extends $1.05M Promissory Note Maturity to September 2026
  • Odyssey Health Loses Exclusive Global Distribution Rights for BreastCheck Product
  • Odyssey Health Finalizes Global BreastCheck™ Distribution, Securing Near-Term Revenue Path

Financial Snapshot

Fiscal year ended July 31, 2025
Net Income
-$1.74M
Diluted EPS
-$0.02
Op. Cash Flow
-$347.39K
Operating Income
-$1.02M
Cash & Equivalents
$19.08K
Debt / Equity
0.00×
Shares Outstanding
96.71M sh
Source: 10-K · filed 2025-10-29 · accession 0001683168-25-007842

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 61,842 shares in ODYY as of the September 15, 2026 settlement, a 247.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 1, 2026, 50.0% of ODYY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)61,842 shares as of September 15, 2026
Change vs prior period▲ 247.8%
Days to cover1.00 at avg daily volume of 253,473
Daily short volume (FINRA facilities)50.0% of 40,790 shares on October 1, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$0.0083 -0.06% today
52-week range · as of 2026-06-12 $0.0046 – $0.125
Market cap
$838.04K
Volume
40.8K (0.2× avg)
3-mo avg 244.3K
Live data · 2026-10-04 21:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ODYY - Latest Insights

ODYY
Jun 12, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0068
Real-time Price: $0.0083 info
Change: +$0.0015 (+22%) info
Market Cap: $838.04K info
ODYY
Jun 12, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0068
Real-time Price: $0.0083 info
Change: +$0.0015 (+22%) info
Market Cap: $838.04K info
ODYY
May 22, 2026, 7:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0195
Real-time Price: $0.0083 info
Change: -$0.0112 (-57%) info
Market Cap: $838.04K info
ODYY
May 11, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0502
Real-time Price: $0.0083 info
Change: -$0.0419 (-83%) info
Market Cap: $838.04K info
ODYY
Apr 24, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0544
Real-time Price: $0.0083 info
Change: -$0.0461 (-85%) info
Market Cap: $838.04K info
ODYY
Mar 11, 2026, 6:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.052
Real-time Price: $0.0083 info
Change: -$0.0437 (-84%) info
Market Cap: $838.04K info
ODYY
Feb 03, 2026, 5:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0648
Real-time Price: $0.0083 info
Change: -$0.0565 (-87%) info
Market Cap: $838.04K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets